mizoribine has been researched along with IgG4 Related Systemic Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, S; Ikeda, Y; Kawaai, S; Kishimoto, M; Nakai, T; Nomura, A; Ohde, S; Okada, M; Suda, M; Tamaki, H | 1 |
1 other study(ies) available for mizoribine and IgG4 Related Systemic Disease
| Article | Year |
|---|---|
Effectiveness and safety of mizoribine for the treatment of IgG4-related disease: a retrospective cohort study.
Topics: Biomarkers; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2021 |